02282017Headline:

Ohio Valley, West Virginia

HomeWest VirginiaOhio Valley

Roopal Luhana

Granddaughter Files Xarelto Lawsuit After Her Grandmother Dies of Bleeding

On November 12, 2015, a Louisiana resident filed a new Xarelto lawsuit in the Eastern District of Louisiana, the current location of the consolidated Xarelto MultiDistrict Litigation (“MDL”). The plaintiff blames Xarelto for her grandmother’s death, and seeks in excess […]

Eric T. Chaffin

Ohio Couple Files Xarelto Lawsuit for Life-Threatening Injuries

On October 5, 2015, a husband and wife from Morrow County, Ohio, filed a new Xarelto lawsuit in the U.S. District Court for the Southern District of Ohio. They allege that manufacturers Janssen Pharmaceuticals, parent company Johnson & Johnson, and […]

Eric T. Chaffin

Bellwether Trial Dates Scheduled for Xarelto MDL

In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana. Since then, all product liability complaints concerning Xarelto (rivaroxaban) filed in federal court have been […]

Roopal Luhana

Might Risperdal Increase Risk of Birth Defects?

Janssen Pharmaceuticals and parent company, Johnson & Johnson, have been named as defendants in a number of lawsuits concerning the anti-psychotic drug, Risperdal (risperidone). Plaintiffs claim the companies failed to provide adequate warnings about serious side effects like abnormal breast […]

Roopal Luhana

Meeting Scheduled to Review Risperdal Claims in Philadelphia

A number of lawsuits have been filed against Risperdal manufacturer Janssen Pharmaceuticals and parent company Johnson & Johnson (J&J). Plaintiffs claim that the drug companies failed to provide adequate warnings about the risks of the anti-psychotic medication, including its potential […]

Eric T. Chaffin

Testosterone Lawsuit Update Shows Cases Increasing

Men allegedly injured by testosterone therapy products are stepping forward. In January 2014, the FDA reported they were investigating the “risk of stroke, heart attack, and death in men taking FDA-approved testosterone products.” Since then, manufacturers of so-called “Low T” […]

Eric T. Chaffin

Plaintiffs Seek Class Action Status in AndroDerm Lawsuit

Men 65 years and older who take testosterone injections or use testosterone gel apparently have double the risk of suffering a heart attack as men who don’t. That was the conclusion of a PLOS One study, published in January 2014. […]

Eric T. Chaffin

Study Finds Link between Testosterone Therapy and Brain Health Damage in Some Men

A study released by the University of North Texas Health Center found an increased risk of brain damage among Caucasian men taking a form of testosterone therapy treatment.  The article, published in the Journal of Alzheimer’s disease, came to the […]

Roopal Luhana

Arkansas Attorney General Asks Supreme Court to Reconsider Decision Tossing out $1.2 Billion Risperdal Judgment

Arkansas Attorney General Dustin McDaniel wants the Arkansas state Supreme Court to “reconsider its decision” in the case against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, Inc. over Risperdal.  According to an article in The Washington Times, the state […]

Roopal Luhana

J&J Allegedly Over-Promoted Risperdal and Paid the Price

In November 2013, the New York Times reported that Johnson & Johnson (J&J) would pay more than $2.2 billion in fines to settle claims that it overpromoted Risperdal, an antipsychotic drug, to vulnerable populations like the elderly, children, and adolescents. […]